| Role |
Name |
Disclosure |
Details |
| Author | Roy H Lubit, MD, PhD, Clinical Faculty, Department of Child Psychiatry, New York University School of Medicine; Private Practice | Nothing to disclose | Details | | Coauthor | Elizabeth A Finley-Belgrad, MD, Clinical Assistant Professor, Department of Psychiatry, Northeastern Ohio Universities College of Medicine | Nothing to disclose | Details | | Medical Editor | Carol Diane Berkowitz, MD, Executive Vice Chair, Department of Pediatrics, Professor, Harbor-University of California at Los Angeles Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | CME Editor | Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine | Baxter Pfizer | Details | | Chief Editor | Caroly Pataki, MD, Professor of Clinical Psychiatry, Department of Psychiatry and Biobehavioral Sciences, Division Chair of Child and Adolescent Psychiatry, Director of Training, Child and Adolescent Psychiatry Residency Program, University of Southern California Keck School of Medicine | Nothing to disclose | Details |
|